Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Kourosh Zarringhalam, Jeffrey H. Chuang et al.|Modern Pathology|2021Cited by 166
Deep learning trained on H&E tumor ROIs predicts HER2 status and Trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Kourosh Zarringhalam, Aileen I. Fernandez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 3